It is difficult to say what is impossible for the dreams of yesterday are the hopes of today and the reality of tomorrow. – Robert H. Goddard
About AMDA
The Acid Maltase Deficiency Association formed to assist in funding research and to promote public awareness of Acid Maltase Deficiency, also known as Pompe’s Disease.
Recently Added
Audentes Pompe Program Update
Audentes has released a Pompe Program...
Spark Therapeutics Clinical Trial FAQ
Spark Therapeutics has developed a...
Patient Focused Drug Development Meeting—UPDATE
As everyone knows, due to the ongoing...
2020 PCMA Pull For Pompe!—Cancelled
Update: July 8, 2020 It is with great...
AMDA Q and A with Dr. Priya Kishnani on COVID-19 and Pompe
With all of the questions and...
Statement from Spark Therapeutics on COVID-19 and their Pompe Program
Dear IPA Board of Directors, As I’m...
WHAT IS POMPE DISEASE?
Pompe disease is one of a family of 49 rare genetic disorders known as Lysosomal Storage Diseases or LSDs. Pompe disease is also known as Acid Maltase Deficiency or Glycogen Storage Disease type II.
RESEARCH
INITIATIVES
NEWS
CONFERENCES
Get Involved
Your generous contribution will go a long way into improving the quality of life of Pompe Disease Patients worldwide. Donations go towards Pompe Disease Research.
Acid Maltase Deficiency Association
If you are interested in learning more about Pompe Disease and would like to make a contribution in support of necessary research, please contact us at:
(210) 494-6144
info@amda-pompe.org
AMDA
PO Box 700248
San Antonio, Texas 78270 USA